Trustmark National Bank Trust Department’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-1,565
Closed -$419K – 336
2016
Q1
$419K Sell
1,565
-435
-22% -$125K 0.06% 196
2015
Q4
$625K Sell
2,000
-4,646
-70% -$1.38M 0.09% 175
2015
Q3
$1.81M Buy
6,646
+70
+1% +$21.5K 0.25% 88
2015
Q2
$2M Buy
6,576
+68
+1% +$20.3K 0.27% 82
2015
Q1
$1.94M Buy
6,508
+1,049
+19% +$299K 0.26% 84
2014
Q4
$1.41M Sell
5,459
-408
-7% -$102K 0.19% 118
2014
Q3
$1.42M Buy
5,867
+368
+7% +$82.4K 0.2% 113
2014
Q2
$1.23M Buy
5,499
+156
+3% +$32.3K 0.14% 135
2014
Q1
$1.1M Buy
+5,343
New +$1.06M 0.13% 138
2013
Q4
– Sell
-5,343
Closed -$769K – 351
2013
Q3
$769K Hold
5,343
– – 0.1% 164
2013
Q2
$674K Buy
+5,343
New +$605K 0.09% 172

Other funds holding AGN

Trustmark National Bank Trust Department's AGN Position: Q2 2016 in Review

Trustmark National Bank Trust Department sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 1,565 shares — an estimated $419K sold.

Trustmark National Bank Trust Department first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $2M in Q2 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Trustmark National Bank Trust Department reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Trustmark National Bank Trust Department sold 1,565 Allergan plc shares in Q2 2016, an estimated $419K.
  • Trustmark National Bank Trust Department first reported a position in Allergan plc in Q2 2013 and held it in 11 quarters.
  • Trustmark National Bank Trust Department's Allergan plc position peaked at $2M in Q2 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Trustmark National Bank Trust Department's 13F filing for Q2 2016, filed 15 Aug 2016.